YESCARTA dispersion cellulaire sol perf
7680669860011
CH-66986
L01XL03
07.16.4.
1 / 3
google
Details
- Product number
- 6698601
- CPT
- -
- Packaging group
- 68ml
- Unit
- Beutel
- Composition
- Beutel: axicabtagenum ciloleucelum Zelldispersion von 0.4 – 2 x 10e8 Zellen/Einzel-Infusionsbeutel (68 ml), natrii chloridum, albuminum humanum, CryoStor CS10 34 ml corresp. dimethylis sulfoxidum 5 % V/V, ad praeparationem pro.
Articles (1)
Yescarta
Beutel
68ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
axicabtagenum ciloleucelum
|
- | Substance | Wirkstoff (Principe actif) |
|
natrii chloridum
|
- | Substance | HNIDK |
|
albuminum humanum
|
- | Substance | HNIDK |
|
CryoStor CS10
|
34.0 ML | Substance | HIMDK |
|
dimethylis sulfoxidum
|
5.0 PVV | Substance | HIMDK |
Authorization holder
Gilead Sciences Switzerland Sàrl
6300 Zug
Authorization information
- Swissmedic authorization number
- 66986
- Drug name
- Yescarta
- Galenic form
- LSPA
- ATC Code
- L01XL03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 17/04/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.4.
- Domain
- Human medicine
Packaging details
- Description (FR)
- YESCARTA dispersion cellulaire sol perf
- Description (DE)
- YESCARTA Zelldispersion Inf Lös
- Market launch
- 17/04/2019
- Narcotic (BTM)
- No
Application methods
IV